Overview

Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Neuropathic pain is caused by a virus commonly associated with chicken pox. This virus may become dormant in the nervous system and later reactivate causing herpes zoster, also known as "shingles". Post-herpetic neuralgia (PHN) is a persistent pain in the area of healed skin lesions. This study will test the safety and efficacy of treating PHN patients with the analgesic patch, Bupivacaine TTS (Eladur™).
Phase:
Phase 2
Details
Lead Sponsor:
Durect
Treatments:
Bupivacaine